U000328, a novel ALK2/3 kinase inhibitor, represses hepcidin and significantly improves the phenotype of IRIDA

Audrey Belot; Ophélie Gourbeyre; Alexis Fay; Anais Palin; Celine Besson-Fournier; Chloé Latour; Corey R. Hopkins; George F. Tidmarsh; Hélène Coppin; Marie Paule Roth; Matthew R. Ritter; Charles C. Hong; Delphine Meynard

doi:10.3324/HAEMATOL.2019.236133

U000328, a novel ALK2/3 kinase inhibitor, represses hepcidin and significantly improves the phenotype of IRIDA

Audrey Belot, Ophélie Gourbeyre, Alexis Fay, Anais Palin, Celine Besson-Fournier, Chloé Latour, Corey R. Hopkins, George F. Tidmarsh, Hélène Coppin, Marie Paule Roth, Matthew R. Ritter, Charles C. Hong, Delphine Meynard

Research output: Contribution to journal › Article › peer-review

14 Scopus citations

Original language	English (US)
Journal	Haematologica
Volume	105
Issue number	3
DOIs	https://doi.org/10.3324/HAEMATOL.2019.236133
State	Published - Mar 1 2020

ASJC Scopus subject areas

Hematology

Access to Document

10.3324/HAEMATOL.2019.236133

Cite this

@article{f394bd7e6ef34351b48efbbcfbe66d7a,

title = "U000328, a novel ALK2/3 kinase inhibitor, represses hepcidin and significantly improves the phenotype of IRIDA",

author = "Audrey Belot and Oph{\'e}lie Gourbeyre and Alexis Fay and Anais Palin and Celine Besson-Fournier and Chlo{\'e} Latour and Hopkins, {Corey R.} and Tidmarsh, {George F.} and H{\'e}l{\`e}ne Coppin and Roth, {Marie Paule} and Ritter, {Matthew R.} and Hong, {Charles C.} and Delphine Meynard",

note = "Funding Information: D.M. was supported by the Cooley{\textquoteright}s Anemia Foundation, the French Foundation for Rare Diseases, the R{\'e}gion Midi-Pyr{\'e}n{\'e}es and ANR (ANR-17-CE14-0036-01 and ANR-17-CE14-0031-01). H.C. and M.-P.R. were supported in part by grants from FRM (DEQ2000326528) and ANR (ANR-13-BSV3-0015-01). This work was also supported by the “Programme des Investissements d{\textquoteright}Avenir” ANINFIMIP (ANR-11EQPX-0003).",

year = "2020",

month = mar,

day = "1",

doi = "10.3324/HAEMATOL.2019.236133",

language = "English (US)",

volume = "105",

journal = "Haematologica",

issn = "0390-6078",

publisher = "Ferrata Storti Foundation",

number = "3",

}

TY - JOUR

T1 - U000328, a novel ALK2/3 kinase inhibitor, represses hepcidin and significantly improves the phenotype of IRIDA

AU - Belot, Audrey

AU - Gourbeyre, Ophélie

AU - Fay, Alexis

AU - Palin, Anais

AU - Besson-Fournier, Celine

AU - Latour, Chloé

AU - Hopkins, Corey R.

AU - Tidmarsh, George F.

AU - Coppin, Hélène

AU - Roth, Marie Paule

AU - Ritter, Matthew R.

AU - Hong, Charles C.

AU - Meynard, Delphine

N1 - Funding Information: D.M. was supported by the Cooley’s Anemia Foundation, the French Foundation for Rare Diseases, the Région Midi-Pyrénées and ANR (ANR-17-CE14-0036-01 and ANR-17-CE14-0031-01). H.C. and M.-P.R. were supported in part by grants from FRM (DEQ2000326528) and ANR (ANR-13-BSV3-0015-01). This work was also supported by the “Programme des Investissements d’Avenir” ANINFIMIP (ANR-11EQPX-0003).

PY - 2020/3/1

Y1 - 2020/3/1

UR - http://www.scopus.com/inward/record.url?scp=85081633777&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85081633777&partnerID=8YFLogxK

U2 - 10.3324/HAEMATOL.2019.236133

DO - 10.3324/HAEMATOL.2019.236133

M3 - Article

C2 - 31806689

AN - SCOPUS:85081633777

SN - 0390-6078

VL - 105

JO - Haematologica

JF - Haematologica

IS - 3

ER -

U000328, a novel ALK2/3 kinase inhibitor, represses hepcidin and significantly improves the phenotype of IRIDA

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this